CUSIP 05153U107COMAURAQ4 2025
38 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Matrix Capital Management Company, LP | 6.92M | $37.73M |
| 2 | Frazier Life Sciences Management, L.P. | 5.10M | $27.80M |
| 3 | Adage Capital Partners Gp, L.L.C. | 4.88M | $26.60M |
| 4 | Long Focus Capital Management, LLC | 4.62M | $25.18M |
| 5 | Suvretta Capital Management, LLC | 4.37M | $23.83M |
| 6 | Blackrock, Inc. | 3.56M | $19.40M |
| 7 | Medicxi Ventures Management (Jersey) Ltd | 3.04M | $16.57M |
| 8 | Vanguard Group Inc | 2.94M | $16.00M |
| 4 | Aug 14, 2025 | Frazier Life Sciences Public Fund, L.P. | 13G/A | 5.0% | 3.11M | SEC |
| 5 | Aug 13, 2025 | Suvretta Capital Management, LLC | 13G/A | 7.6% | 4.70M | SEC |
| 6 | Jul 16, 2025 | Blackrock, Inc. | 13G/A | 4.9% | 3.04M | SEC |
| 7 | May 23, 2025 | Frazier Life Sciences Public Fund, L.P. | 13G | 9.9% | 6.32M | SEC |
| 8 | May 19, 2025 | Matrix Capital Management Company LP | 13D/A | 11.2% | — | SEC |
| 9 | May 15, 2025 | Long Focus Capital Management, LLC | 13G/A | 6.6% | 3.32M | SEC |
| 10 | May 14, 2025 | Eventide Asset Management, LLC | 13G/A | — | — | SEC |
See the full Schedule 13D/13G history for Aura Biosciences Inc.
Unlock full history| 9 |
| Franklin Resources Inc |
| 2.20M |
| $11.98M |
| 10 | Nantahala Capital Management, LLC | 2.12M | $11.54M |